Thomas M. Drake

CXCR2 inhibition enables NASH-HCC immunotherapy

Jack Leslie, John B. G. Mackey, Thomas Jamieson et al. · Gut · 2022 · 228 citations · Full text

Medicine, Immunology, Oncology +17

Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID‐19

Daniel Munblit, Polina Bobkova, Ekaterina Spiridonova et al. · Clinical & Experimental Allergy · 2021 · 201 citations · Full text

Nursing, Infectious Diseases, Internal Medicine +10

Risk factors for long-term consequences of COVID-19 in hospitalised adults in Moscow using the ISARIC Global follow-up protocol: StopCOVID cohort study

Daniel Munblit, Polina Bobkova, Ekaterina Spiridonova et al. · medRxiv · 2021 · 39 citations · Full text

Nursing, Infectious Diseases, Internal Medicine +17

Hepatic glutamine synthetase controls N5-methylglutamine in homeostasis and cancer

Víctor H. Villar, Maria Francesca Allega, Ruhi Deshmukh et al. · Nature Chemical Biology · 2022 · 29 citations · Full text

Life Sciences, Biochemistry, Cancer Biology +14

Human-correlated genetic models identify precision therapy for liver cancer

Miryam Müller, Stephanie May, H. G. HALL et al. · Nature · 2025 · 25 citations · Full text

Medicine, Molecular Genetics, Oncology +16